期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | NEUROCHEMICAL RESEARCH LetPub Score 6.8
50 ratings
Rate
Reputation 7.6 Influence 5.4 Speed 9.4 | ||||||||||||||||||||
期刊簡稱 | NEUROCHEM RES | ||||||||||||||||||||
ISSN | 0364-3190 | ||||||||||||||||||||
E-ISSN | 1573-6903 | ||||||||||||||||||||
h-index | 105 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 2.70%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | https://www.springer.com/11064 | ||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/nere | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Springer US | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||
創刊年 | 1976 | ||||||||||||||||||||
每年文章數 | 214每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 13.68% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0364-3190%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: About 6.0 month(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: About 62.5% | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 5 下一頁 末頁 (頁 | |
[NEUROCHEMICAL RESEARCH] 的評論 | 撰寫評論 |
作者: 虎鹤天云 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-24 22:04:07 評論於 Review speed: 3.0 | Submission hit rate: 50.0 Research focus: oligodendrocytes, demyelination; molecular biology; neuroscience Experience sharing: Submission accepted Jan 17, 2024 Submission under peer review Jan 12, 2024 Submission passed technical check Jan 12, 2024 Revision received Jan 11, 2024 Submission under peer review Dec 18, 2023 Submission passed technical check Dec 18, 2023 Revision received Dec 17, 2023 Submission under peer review Oct 24, 2023 Technical check Submission status Date Submission passed technical check Oct 24, 2023 Submission is under technical check Oct 22, 2023 Submission received Submission status Date Submission received Oct 22, 2023(0) 讚! | 虎鹤天云 |
作者: 虎鹤天云 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-24 19:29:10 評論於 Yes, language issues need to be sent back to the reviewers for a second review, which usually takes about a week(0) 讚! | 虎鹤天云 |
作者: 虎鹤天云 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-12 19:45:50 評論於 This magazine needs to go through another round of revision for language issues, and the external review process is very slow(0) 讚! | 虎鹤天云 |
作者: 韵宁来了 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-08 23:54:39 評論於 Hello, in the magazine, it asks for the author's institution. I can only add the school and can't add a specific department. How should I proceed with this?(0) 讚! | 韵宁来了 |
作者: 韵宁来了 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-08 14:09:04 評論於 Hello, in the magazine it requires the author's affiliation. I can only add the school and not the specific department. How should I proceed with this?(0) 讚! | 韵宁来了 |
作者: 辛酉小娘子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-27 11:59:46 評論於 Are you accepting pure clinical cases?(0) 讚! | 辛酉小娘子 |
作者: 虎鹤天云 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-24 20:23:27 評論於 Research focus: Molecular biology Experience sharing: Hello, what is the status of peer review? Is it internal or external?(0) 讚! | 虎鹤天云 |
作者: 孤云钰岩 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-19 17:15:43 評論於 Review Speed: 4.0 | Submission Hit Rate: 60.0 Emphasized Research Area: Neural Experiences Share: First submission to SCI, this journal has a very high efficiency. First submission at the end of March, returned with major revisions a month and a half later. Revised and resubmitted by the end of May, asked to make some minor changes two weeks later. Accepted the day after the revisions were made. Overall, the efficiency is very high, as long as the requested modifications are made without major issues, it will be accepted(0) 讚! | 孤云钰岩 |
作者: 行云爱武 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-18 08:15:43 評論於 Review speed: 1.0 | Submission acceptance rate: 50.0 Focus on research direction: Neural experience sharing First submission to SCI, I thought this journal was very efficient. Submitted in December, received major revisions a month later. Returned in February, received major revisions a month later. Returned in March, made some minor revisions in about 2 weeks. Accepted on the same day of the revisions on April 17th. Overall, the efficiency is very high, and if revisions are made according to the requirements without major issues, it will be accepted(0) 讚! | 行云爱武 |
作者: 逍遥英华 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-09 10:41:33 評論於 Do you accept submissions? Could you please share the submission process and timeline? Thank you(0) 讚! | 逍遥英华 |
作者: Leo Pollitt 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-09 11:55:46 評論於 Hello, may I ask at what stage your article is now?(0) 讚! | Leo Pollitt |
作者: 傲寒睿博 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-16 18:55:35 評論於 Is there any reason for rejection after submitting for external review?(0) 讚! | 傲寒睿博 |
作者: Douglas Emerson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-02 22:40:40 評論於 Too slow(0) 讚! | Douglas Emerson |
作者: Douglas Emerson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-10 18:11:46 評論於 Invest cautiously, editors are not patient, information will not be updated(0) 讚! | Douglas Emerson |
作者: 暴风志青 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-13 15:48:05 評論於 They will send the progress link to the corresponding author, who needs to click on it to see(0) 讚! | 暴风志青 |
作者: 雨巷少年君豪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-14 19:18:20 評論於 How long has everyone been assigned as an editor? I've been assigned for 2 weeks already(0) 讚! | 雨巷少年君豪 |
作者: 雨巷少年君豪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-14 16:47:47 評論於 The account of the corresponding author can see(0) 讚! | 雨巷少年君豪 |
作者: 犬走奇邃 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-12 13:46:22 評論於 Hello, after submitting a manuscript, why can't I see the submission status? Where can I see the submission status in the magazine? Please reply, thank you(0) 讚! | 犬走奇邃 |
作者: 雨巷少年君豪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-05 23:15:05 評論於 How are you doing now?(0) 讚! | 雨巷少年君豪 |
作者: 东京洁雅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-10 14:37:52 評論於 Has Springer recently changed its submission system? Why is my submission still in the status of "editor appointed" after a week? Could it be that the change in system is also affecting the editorial review process(0) 讚! | 东京洁雅 |
作者: Bing Edison 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-22 23:49:09 評論於 How long does it take from acceptance to publication?(0) 讚! | Bing Edison |
作者: 晴空万里的小可爱 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2021-12-06 09:12:30 評論於 2021.10.02 Submission 2021.11.19 Rework 2021.12.02 Revised 2021.12.04 Accept(0) 讚! | 晴空万里的小可爱 |
作者: 巴蜀敏丽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-10-28 12:34:47 評論於 Hello, do you have any clinical studies on drug delivery?(0) 讚! | 巴蜀敏丽 |
作者: 衔萶彦 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2021-10-09 17:56:20 評論於 2021.7.5 Submission 2021.9.2 (Thursday) First review returned, two reviewers suggested major revisions in some parts and minor revisions in others, no additional experimental section. 2021.9.20 (Monday) Resubmission after revisions. 2021.10.8 Accepted. The IF of Neurochemical Research in 2020 was shown to be 3.996 in 2021.(0) 讚! | 衔萶彦 |
作者: 西风寒烟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-10-02 15:44:01 評論於 But I saw that there are charges written on the official website(0) 讚! | 西风寒烟 |
首頁 上一頁 1 2 3 4 5 下一頁 末頁 (頁 |
Contact us